PCSK9 and familial hyperaldosteronism: We presently have a variety of medications to reduce LDL cholesterol in patients with FH, including statins, ezetimibe, resin, probucol, PCSK9 inhibitors, lomitapide (MTTP inhibitor), and evinacumab (ANGPTL3 inhibitor).